We develop bench-to-bedside technologies, including diagnostics and therapeutics, for human immune diseases. Our lab is also active in vaccine biology, both for inducing protective immunity to pathogens and for turning off immune responses in autoimmune diseases. We have recently pivoted efforts to study SARS-CoV-2, testing the hypothesis that the virus causes autoimmunity. Major goals of our studies are: